M. Kay
Molecular Biology · 2000–2014
A researcher in the Science corpus: 15 papers; trusts 7 researchers and is trusted by 8 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 100 citations into it; #5,630 of 17,773 by trust here, #2,115 by citations
- Genetics — 61 citations into it; #1,873 of 6,854 by trust here, #486 by citations
- Surgery — 6 citations into it
- Animal Science and Zoology — 5 citations into it
Whom M. Kay trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Kay overall
Papers from M. Kay's perspective
Ordered by how strongly the researchers M. Kay trusts endorse each paper. Same corpus, a different order for every researcher.
- LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 (Science)
- Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 (Nature Medicine)
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector (Nature Genetics)
- Variation in the reversibility of evolution (Nature)
- RNA interference targeting Fas protects mice from fulminant hepatitis (Nature Medicine)
- Murine Leukemia Induced by Retroviral Gene Marking (Science)
- Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. (Science)
- siRNA-mediated gene silencing in vitro and in vivo (Nature Biotechnology)
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways (Nature)
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy (Science)
Their papers
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. (2006) — 627 citations
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways (2006) — 1,751 citations
- Human tRNA-derived small RNAs in the global regulation of RNA silencing. (2010) — 700 citations
- A Nonviral Minicircle Vector for Deriving Human iPS Cells (2010) — 740 citations
- Inhibition of hepatitis B virus in mice by RNA interference (2003) — 626 citations
- Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response (2006) — 2,132 citations
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector (2000) — 1,049 citations
- Progress and problems with the use of viral vectors for gene therapy (2003) — 2,490 citations
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B (2011) — 1,797 citations
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses (2008) — 629 citations
- Sarcoma Derived from Cultured Mesenchymal Stem Cells (2007) — 648 citations
- State-of-the-art gene-based therapies: the road ahead (2011) — 679 citations
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B (2014) — 1,138 citations
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice (2007) — 804 citations
- Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics (2001) — 1,397 citations